Lotus upgrades facility
Generic drugmaker Lotus Pharmaceuticals Co (美時化學製藥) yesterday announced that it has begun upgrading its manufacturing facility in Nantou County to expand the production of oral oncology products. The upgrade is expected to be completed in five years and cost tens of millions of US dollars, the company said, adding that its board has approved capital expenditure of US$11 million for this year. The Nantou site has been audited by local, US, EU and Japanese regulatory authorities, enabling it to manufacture products for nearly every market in the world, the firm said. In addition to standard solid oral dose manufacturing, the company can produce hormonal products, soft gelatin capsules, and cytotoxic and high-potency molecules, it said.
Health2Sync launches app
Taipei-based Health2Sync (慧康生活科技) yesterday launched HealthPass, an app that grants its users full control of their health data using blockchain technology. The start-up teamed up with Bitmark Inc, a Taipei-based blockchain developer, to register users’ health data as their personal digital property. Users would be able to selectively allow certain companies and services to access their health data as part of a monetization scheme. The start-up has also tapped CTBC Bank (中信銀行) to use the lender’s blockchain-based solution to enable transactions resulting from monetization. With the help of health data analysis, insurers would be able to create tailored products based on each user’s health, the firm said.
Pharmally sales up 20.27%
Pharmally International Holding Co (康友製藥), a maker of large-volume parenteral solutions for vaccines and intravenous medicines, yesterday announced that net income last year rose 17.44 percent year-on-year to NT$1.1 billion (US$35.59 million), or earnings per share of NT$14.29, while sales rose 20.27 percent to NT$5.18 billion. Pharmally shares closed unchanged at NT$214 in Taipei trading yesterday. The shares last year saw a spike in volatility, surging to more than NT$500 on progress made at its Indonesian poultry vaccine production plant, before falling below NT$140 after a filing revealed that company officials were trimming their holdings.
Pegatron revenue slumps
Pegatron Corp (和碩) on Monday reported that revenue last month dropped 33.4 percent month-on-month, but rose 6.2 percent year-on-year to NT$81.65 billion. Revenue in the first two months rose 3.2 percent year-on-year to NT$204.28 billion, it said. The Jakarta Post reported that Pegatron’s new plant in Indonesia is expected to begin operations next month. Separately, Lite-On Technology Corp (光寶科技) on Monday reported that revenue last month declined 30.33 percent month-on-month and 16.6 percent year-on-year to NT$10.87 billion. Revenue in the first two months also fell 10.36 percent to NT$26.48 billion.
Chungwa Picture shares fall
A plan to lay off 2,500 employees sent shares in Chunghwa Picture Tubes Ltd (華映) into a tailspin yesterday, dealers said. The heavy selling emerged after the Taiwan Stock Exchange said that the financially troubled panel maker, which has filed for bankruptcy protection, would have to delist regardless of whether the restructuring plan is approved by the courts. Shares fell by the daily limit of 10 percent to close at NT$0.54.
UNWANTED ATTENTION: In the past two months, the automaker has made headlines, with a Chinese military ban of its vehicles and a protest at an expo Electric vehicle maker Tesla Inc, facing scrutiny in China over safety and customer service complaints, is boosting its engagement with regulators and beefing up its government relations team, industry sources said. Tesla’s change of strategy leading to more behind-the-scenes interaction with policymakers in Beijing compared with relatively little previously shows the seriousness with which the US automaker views the setbacks in its second-biggest market. TALKING SHOP It also comes at a time when China is trying to regulate large and powerful private companies, especially in the technology sector, on concerns about their market dominance. As they do elsewhere, regulators in China, the world’s biggest
Chinese electric vehicle (EV) start-up Nio Inc (蔚來) reported a narrower first-quarter loss, while warning that a global chip shortage would keep a lid on deliveries. The Shanghai-based company posted a net loss of 451 million yuan (US$68.8 million) in the three months ended March 31, compared with 1.69 billion yuan a year earlier, it said in a statement. It also marked an improvement on the 1.39 billion yuan net loss it posted in the fourth quarter of last year. Revenue rose to 7.98 billion yuan, beating estimates of 7.16 billion yuan. Nio delivered 20,060 vehicles in the quarter, a 423 percent increase from
Dell Technologies Inc has agreed to sell its Boomi cloud business to private equity firms Francisco Partners and TPG in a cash deal valued at US$4 billion, as part of efforts by chief executive officer Michael Dell to trim down the PC maker. The deal is expected to close by the end of this year, the companies said in a statement on Sunday without providing additional details of the terms. Dow Jones had earlier reported that the companies were near a deal. Boomi specializes in integrating different cloud platforms for companies and has more than 15,000 customers. Dell agreed to acquire the company for
Intel Corp wants 8 billion euros (US$9.7 billion) in public subsidies toward building a semiconductor factory in Europe, chief executive officer Pat Gelsinger was cited as saying on Friday, as the region seeks to reduce its reliance on imports amid a shortage of supplies. The pitch is the first time that Gelsinger has publicly put a figure on how much state aid he would want, as Intel campaigns to take on Asian rivals in contract manufacturing. “What we’re asking from both the US and the European governments is to make it competitive for us to do it here, compared to in Asia,”